Pramipexole, a dopamine D2 autoreceptor agonist, decreases the extracellular concentration of dopamine in vivo (Q48686975)

14 February 2018

title

Pramipexole, a dopamine D2 autoreceptor agonist, decreases the extracellular concentration of dopamine in vivo (English)

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90666-E

28 October 2022

0 references

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90666-E

28 October 2022

author name string

A. J. Carter

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1685123

28 October 2022

R. E. Müller

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1685123

28 October 2022

language of work or name

English

0 references

publication date

1 July 1991

1 reference

14 February 2018

23 July 1991

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1685123

full work available at URL

28 October 2022

https://api.elsevier.com/content/article/PII:001429999190666E?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90666-E

https://api.elsevier.com/content/article/PII:001429999190666E?httpAccept=text/plain

28 October 2022

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90666-E

European Journal of Pharmacology

28 October 2022

published in

1 reference

14 February 2018

volume

200

1 reference

14 February 2018

issue

1

1 reference

14 February 2018

page(s)

65-72

1 reference

14 February 2018

Selective stimulation of dopamine and noradrenaline autoreceptors by B-HT 920 and B-HT 933, respectively

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90666-E

Stimulation of D1 dopamine receptors reveals direct effects of the preferential dopamine autoreceptor agonist B-HT 920 on postsynaptic dopamine receptors

28 October 2022

2

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90666-E

B-HT 920 is a full agonist at both pre- and postsynaptic D-2 dopamine receptors

28 October 2022

3

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90666-E

Effects of B-HT 920 and B-HT 933 on dopamine and noradrenaline autoreceptors in the rat brain.

28 October 2022

4

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90666-E

Dopamine D-2 agonists with high and low efficacies: differentiation by behavioural techniques

28 October 2022

5

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90666-E

28 October 2022

Brain microdialysis

6

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90666-E

Regional cerebral glucose phosphorylation and blood flow after insertion of a microdialysis fiber through the dorsal hippocampus in the rat.

28 October 2022

7

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90666-E

Dopamine receptor agonists: intrinsic activity vs. state of receptor

28 October 2022

8

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90666-E

Rapid tolerance to neuroleptic-induced stimulation of dopamine release in freely moving rats

28 October 2022

9

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90666-E

Decrease of prolactin secretion via stimulation of pituitary dopamine D-2 receptors after application of talipexole and SND 919.

28 October 2022

10

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90666-E

D-2 dopamine autoreceptor selective drugs: do they really exist?

28 October 2022

11

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90666-E

Dopamine release and metabolism in awake rats after systemic neuroleptics as studied by trans-striatal dialysis

28 October 2022

12

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90666-E

Effects of locally applied D-1 and D-2 receptor agonists and antagonists studied with brain dialysis

28 October 2022

13

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90666-E

The D-1 antagonist SCH 23390 stimulates while the D-1 agonist SKF 38393 fails to affect dopamine release in the dorsal caudate of freely moving rats

28 October 2022

14

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90666-E

Occurrence of yawning and decrease of prolactin levels via stimulation of dopamine D2-receptors after administration of SND 919 in rats

28 October 2022

16

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90666-E

(—)-Sulpiride activates the firing rate and tyrosine hydroxylase activity of dopaminergic neurons in unanesthetized rats

28 October 2022

17

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90666-E

Rapid determination of norepinephrine, dopamine, serotonin, their precursor amino acids, and related metabolites in discrete brain areas of mice within ten minutes by HPLC with electrochemical detection

28 October 2022

19

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90666-E

Dopamine autoreceptor agonists: resolution and pharmacological activity of 2,6-diaminotetrahydrobenzothiazole and an aminothiazole analogue of apomorphine

28 October 2022

22

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90666-E

Effects of halothane anaesthesia on extracellular levels of dopamine, dihydroxyphenylacetic acid, homovanillic acid and 5-hydroxyindolacetic acid in rat striatum: a microdialysis study

28 October 2022

23

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90666-E

Two dopamine receptors: biochemistry, physiology and pharmacology

28 October 2022

24

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90666-E

The enantiomers of the dopamine agonist N-0437: in vivo and in vitro effects on the release of striatal dopamine

28 October 2022

25

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90666-E

Scope and limitations of in vivo brain dialysis: a comparison of its application to various neurotransmitter systems

28 October 2022

26

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90666-E

Characterization of In Vivo Dopamine Release as Determined by Brain Microdialysis After Acute and Subchronic Implantations: Methodological Aspects

28 October 2022

27

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90666-E

In vivo measurement of dopamine and its metabolites by intracerebral dialysis: changes after d-amphetamine.

28 October 2022

29

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90666-E

Effect of neuroleptic drugs on striatal dopamine release and metabolism in the awake rat studied by intracerebral dialysis

28 October 2022

30

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90666-E

Effect of dopamine D-1 and D-2 receptor selective drugs on dopamine release and metabolism in rat striatum in vivo

28 October 2022

31

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90666-E

28 October 2022

Identifiers

1 reference

14 February 2018

release_6qehtsgh4fayzf4k47leaexp3m

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/6qehtsgh4fayzf4k47leaexp3m

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

14 February 2018